Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 174,116 | 165,423 | 145,678 | 116,178 | 170,019 |
| Receivables | 83,320 | 76,466 | 81,195 | 85,427 | 72,953 |
| Inventories | 15,614 | 17,146 | 18,815 | 15,963 | 9,643 |
| TOTAL | $277,888 | $262,132 | $250,813 | $223,675 | $255,720 |
| Non-Current Assets | |||||
| PPE Net | 18,988 | 17,746 | 15,156 | 13,145 | 11,854 |
| Intangibles | 335,904 | 352,699 | 369,494 | 386,289 | 29,503 |
| Other Non-Current Assets | 11,061 | 11,266 | 11,407 | 11,684 | 9,225 |
| TOTAL | $365,953 | $381,711 | $396,057 | $411,118 | $50,582 |
| Total Assets | $643,841 | $643,843 | $646,870 | $634,793 | $306,302 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 47,495 | 47,281 | 47,069 | 46,859 | 3,833 |
| Accounts payable and accrued liabilities | 10,016 | 6,491 | 8,182 | 6,139 | 6,247 |
| Accrued Expenses | 181,210 | 187,956 | 196,164 | 190,700 | 191,029 |
| TOTAL | $239,451 | $242,437 | $252,111 | $244,374 | $201,765 |
| Non-Current Liabilities | |||||
| Long Term Debt | 110,019 | 121,967 | 133,862 | 145,711 | 7,667 |
| Other Non-Current Liabilities | 108,340 | 106,753 | 105,130 | 103,645 | 9,438 |
| TOTAL | $218,359 | $228,720 | $238,992 | $249,356 | $17,105 |
| Total Liabilities | $457,810 | $471,157 | $491,103 | $493,730 | $218,870 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,756 | 34,582 | 34,526 | 34,336 | 34,051 |
| Common Shares | 35 | 35 | 34 | 34 | 34 |
| Retained earnings | -333,147 | -340,105 | -351,391 | -359,449 | -359,899 |
| TOTAL | $186,031 | $172,686 | $155,767 | $141,063 | $87,432 |
| Total Liabilities And Equity | $643,841 | $643,843 | $646,870 | $634,793 | $306,302 |